**§4.79 Schedule of ratings---eye.**

**[Diseases of the Eye]{.smallcaps}**

Rating

**6000** Choroidopathy, including uveitis, iritis, cyclitis, and
choroiditis.

**6001** Keratopathy.

**6002** Scleritis.

**6006** Retinopathy or maculopathy.

**6007** Intraocular hemorrhage.

**6008** Detachment of retina.

**6009** Unhealed eye injury.

**[General Rating Formula for Diagnostic Codes 6000 through
6009]{.smallcaps}**

Evaluate on the basis of either visual impairment due to the particular
condition or on

incapacitating episodes, whichever results in a higher evaluation.

With incapacitating episodes having a total duration of at least 6 weeks

during the past 12 months 60

With incapacitating episodes having a total duration of at least 4
weeks,

but less than 6 weeks, during the past 12 months 40

With incapacitating episodes having a total duration of at least 2
weeks,

but less than 4 weeks, during the past 12 months 20

With incapacitating episodes having a total duration of at least 1 week,

but less than 2 weeks, during the past 12 months 10

**Note**: For VA purposes, an incapacitating episode is a period of
acute symptoms severe enough to require prescribed bed rest and
treatment by a physician or other healthcare provider.

**6010** Tuberculosis of eye:

Active 100

Inactive: Evaluate under § 4.88c or § 4.89 of this part, whichever is
appropriate.

**6011** Retinal scars, atrophy, or irregularities:

Localized scars, atrophy, or irregularities of the retina, unilateral or
bilateral, that are

centrally located and that result in an irregular, duplicated, enlarged,

or diminished image 10

> Alternatively, evaluate based on visual impairment due to retinal
> scars, atrophy, or irregularities, if this would result in a higher
> evaluation.

**6012** Angle-closure glaucoma:

> Evaluate on the basis of either visual impairment due to angle-closure
> glaucoma or incapacitating episodes, whichever results in a higher
> evaluation.

With incapacitating episodes having a total duration of at least 6 weeks

during the past 12 months 60

With incapacitating episodes having a total duration of at least 4
weeks,

but less than 6 weeks, during the past 12 months 40

With incapacitating episodes having a total duration of at least 2
weeks,

but less than 4 weeks, during the past 12 months 20

Minimum evaluation if continuous medication is required 10

**Note**: For VA purposes, an incapacitating episode is a period of
acute symptoms severe enough to require prescribed bed rest and
treatment by a physician or other healthcare provider.

**6013** Open-angle glaucoma:

Evaluate based on visual impairment due to open-angle glaucoma.

Minimum evaluation if continuous medication is required 10

**6014** Malignant neoplasms (eyeball only):

Malignant neoplasm of the eyeball that requires therapy that is
comparable to

that used for systemic malignancies, i.e., systemic chemotherapy, X-ray
therapy

more extensive than to the area of the eye, or surgery more extensive
than

enucleation 100

**Note**: Continue the 100-percent rating beyond the cessation of any
surgical, X-ray, antineoplastic chemotherapy or other therapeutic
procedure. Six months after discontinuance of such treatment, the
appropriate disability rating will be determined by mandatory VA
examination. Any change in evaluation based upon that or any subsequent
examination will be subject to the provisions of §3.105(e) of this
chapter. If there has been no local recurrence or metastasis, evaluate
based on residuals.

> Malignant neoplasm of the eyeball that does not require therapy
> comparable to that for systemic malignancies:
>
> Separately evaluate visual impairment and nonvisual impairment, e.g.,
> disfigurement (diagnostic code 7800), and combine the evaluations.

**6015** Benign neoplasms (of eyeball and adnexa):

> Separately evaluate visual impairment and nonvisual impairment, e.g.,
> disfigurement (diagnostic code 7800), and combine the evaluations.

**6016** Nystagmus, central 10

**6017** Trachomatous conjunctivitis:

Active: Evaluate based on visual impairment, minimum 30

> Inactive: Evaluate based on residuals, such as visual impairment and
> disfigurement (diagnostic code 7800).

**6018** Chronic conjunctivitis (nontrachomatous):

> Active (with objective findings, such as red, thick conjunctivae,
>
> mucous secretion, etc.)\...\...\...\... \...\.... 10
>
> Inactive: Evaluate based on residuals, such as visual impairment and
> disfigurement (diagnostic code 7800).

**6019** Ptosis, unilateral or bilateral:

> Evaluate based on visual impairment or, in the absence of visual
> impairment, on disfigurement (diagnostic code 7800).

**6020** Ectropion:

Bilateral 20

Unilateral 10

**6021** Entropion:

Bilateral 20

Unilateral 10

**6022** Lagophthalmos:

Bilateral 20

Unilateral 10

**6023** Loss of eyebrows, complete, unilateral or bilateral 10

**6024** Loss of eyelashes, complete, unilateral or bilateral 10

**6025** Disorders of the lacrimal apparatus (epiphora, dacryocystitis,
etc.):

Bilateral 20

Unilateral 10

**6026** Optic neuropathy:

Evaluate based on visual impairment.

**6027** Cataract of any type:

*Preoperative*:

Evaluate based on visual impairment.

*Postoperative*:

> If a replacement lens is present (pseudophakia), evaluate based on
> visual impairment. If there is no replacement lens, evaluate based on
> aphakia.

**6029** Aphakia or dislocation of crystalline lens:

> Evaluate based on visual impairment, and elevate the resulting level
> of visual impairment one step.

Minimum (unilateral or bilateral 30

**6030** Paralysis of accommodation (due to neuropathy of the Oculomotor
Nerve

(cranial nerve III)) 20

**6032** Loss of eyelids, partial or complete:

> Separately evaluate both visual impairment due to eyelid loss and
> nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and
> combine the evaluations.

**6034** Pterygium:

> Evaluate based on visual impairment, disfigurement (diagnostic code
> 7800), conjunctivitis (diagnostic code 6018), etc., depending on the
> particular findings.

**6035** Keratoconus:

Evaluate based on impairment of visual acuity.

**6036** Status post corneal transplant:

Evaluate based on visual impairment.

Minimum, if there is pain, photophobia, and glare sensitivity 10

**6037** Pinguecula:

Evaluate based on disfigurement (diagnostic code 7800).

**[Impairment of Central Visual Acuity]{.smallcaps}**

**6061** Anatomical loss of both eyes^1^ 100

**6062** No more than light perception in both eyes^1^ 100

**6063** Anatomical loss of one eye: ^1^

In the other eye 5/200 (1.5/60). 100

In the other eye 10/200 (3/60) 90

In the other eye 15/200 (4.5/60) 80

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 60

In the other eye 20/50 (6/15) 50

In the other eye 20/40 (6/12) 40

**6064** No more than light perception in one eye: ^1^

In the other eye 5/200 (1.5/60) 100

In the other eye 10/200 (3/60) 90

In the other eye 15/200 (4.5/60) 80

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 50

In the other eye 20/50 (6/15) 40

In the other eye 20/40 (6/12) 30

**6065** Vision in one eye 5/200 (1.5/60):

In the other eye 5/200 (1.5/60) ^1^100

In the other eye 10/200 (3/60) 90

In the other eye 15/200 (4.5/60) 80

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 50

In the other eye 20/50 (6/15) 40

In the other eye 20/40 (6/12) 30

**6066** Visual acuity in one eye 10/200 (3/60) or better:

Vision in one eye 10/200 (3/60):

In the other eye 10/200 (3/60 90

In the other eye 15/200 (4.5/60) 80

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 50

In the other eye 20/50 (6/15) 40

In the other eye 20/40 (6/12) 30

Vision in one eye 15/200 (4.5/60):

In the other eye 15/200 (4.5/60) 80

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 40

In the other eye 20/50 (6/15) 30

In the other eye 20/40 (6/12) 20

Vision in one eye 20/200 (6/60):

In the other eye 20/200 (6/60) 70

In the other eye 20/100 (6/30) 60

In the other eye 20/70 (6/21) 40

In the other eye 20/50 (6/15) 30

In the other eye 20/40 (6/12) 20

Vision in one eye 20/100 (6/30):

In the other eye 20/100 (6/30) 50

In the other eye 20/70 (6/21) 30

In the other eye 20/50 (6/15) 20

In the other eye 20/40 (6/12) 10

Vision in one eye 20/70 (6/21):

In the other eye 20/70 (6/21) 30

In the other eye 20/50 (6/15) 20

In the other eye 20/40 (6/12) 10

Vision in one eye 20/50 (6/15):

In the other eye 20/50 (6/15) 10

In the other eye 20/40 (6/12) 10

Vision in one eye 20/40 (6/12):

In the other eye 20/40 (6/12) 0

^1^Review for entitlement to special monthly compensation under 38 CFR
3.350.

**[Ratings for Impairment of Visual Fields]{.smallcaps}**

**6080** Visual field defects:

Homonymous hemianopsia 30

Loss of temporal half of visual field:

Bilateral 30

Unilateral 10

Or evaluate each affected eye as 20/70 (6/21).

Loss of nasal half of visual field:

Bilateral 10

Unilateral 10

Or evaluate each affected eye as 20/50 (6/15).

Loss of inferior half of visual field:

Bilateral 30

Unilateral 10

Or evaluate each affected eye as 20/70 (6/21).

Loss of superior half of visual field:

Bilateral 10

Unilateral 10

Or evaluate each affected eye as 20/50 (6/15).

Concentric contraction of visual field:

With remaining field of 5 degrees: ^1^

Bilateral 100

Unilateral 30

Or evaluate each affected eye as 5/200 (1.5/60).

With remaining field of 6 to 15 degrees:

Bilateral 70

Unilateral 20

Or evaluate each affected eye as 20/200 (6/60).

With remaining field of 16 to 30 degrees:

Bilateral 50

Unilateral 10

Or evaluate each affected eye as 20/100 (6/30).

With remaining field of 31 to 45 degrees:

Bilateral 30

Unilateral 10

Or evaluate each affected eye as 20/70 (6/21).

With remaining field of 46 to 60 degrees:

Bilateral 10

Unilateral 10

Or evaluate each affected eye as 20/50 (6/15).

**6081** Scotoma, unilateral:

> Minimum, with scotoma affecting at least one-quarter of the visual
> field
>
> (quadrantanopsia) or with centrally located scotoma of any size 10
>
> Alternatively, evaluate based on visual impairment due to scotoma, if
> that would result in a higher evaluation.

^1^Review for entitlement to special monthly compensation under 38 CFR
3.350.

**[Ratings for Impairment of Muscle Function]{.smallcaps}**

Equivalent

visual acuity

Degree of diplopia

**6090** Diplopia (double vision):

> \(a\) Central 20 degrees 5/200 (1.5/60)
>
> \(b\) 21 degrees to 30 degrees
>
> \(1\) Down 15/200 (4.5/60)
>
> \(2\) Lateral 20/100 (6/30)
>
> \(3\) Up 20/70 (6/21)
>
> \(c\) 31 degrees to 40 degrees
>
> \(1\) Down 20/200 (6/60)
>
> \(2\) Lateral 20/70 (6/21)
>
> \(3\) Up 20/40 (6/12)

**Note**: In accordance with 38 CFR 4.31, diplopia that is occasional or
that is correctable with spectacles is evaluated at 0 percent.

**6091** Symblepharon:

> Evaluate based on visual impairment, lagophthalmos (diagnostic code
> 6022), disfigurement (diagnostic code 7800), etc., depending on the
> particular findings.

(Authority: 38 U.S.C. 1155)

\[43 FR 45354, Oct. 2, 1978, as amended at 73 FR 66550, Nov. 10, 2008\]

**Supplement *Highlights* reference**: 46(1)